Opposing effects of bim and bcl-2 on lung endothelial cell migration

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 299, Issue 5, 2010, Pages

  Grutzmacher, Cathy ^a   Park, SunYoung ^a   Elmergreen, Tammy L ^a   Tang, Yixin ^a   Scheef, Elizabeth A ^a   Sheibani, Nader ^a   Sorenson, Christine M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Angiogenesis; Apoptosis; Capillary morphogenesis; Extracellular matrix proteins

Indexed keywords

ALPHA5 INTEGRIN; BETA1 INTEGRIN; BETA3 INTEGRIN; BIM PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBRONECTIN; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; PROTEIN BCL 2; VASCULAR CELL ADHESION MOLECULE 1; VITRONECTIN; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRANCHING MORPHOGENESIS; CAPILLARY; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; LUNG ALVEOLUS; LUNG ENDOTHELIUM; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ANIMALS; ANTIMETABOLITES; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL ADHESION MOLECULES; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; FLUOROURACIL; INTEGRINS; LUNG; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 78249259696     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00390.2009     Document Type: Article

References (45)

1. Blanes MG, Oubaha M, Rautureau Y, Gratton JP. Phosphorylation of tyrosine 801 of vascular endothelial growth factor receptor-2 is necessary for Akt-dependent endothelial nitric-oxide synthase activation and nitric oxide release from endothelial cells. J Biol Chem 282: 10660-10669, 2007. (Pubitemid 47093458)
2. Bouillet P, Cory S, Zhang LC, Strasser A, Adams JM. Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. Dev Cell 1: 645-653, 2001. (Pubitemid 33586117)
3. Canfield AE, Schor AM. Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells. J Cell Sci 108: 797-809, 1995.
4. DeLisser HM, Helmke BP, Cao G, Egan PM, Taichman D, Fehrenbach M, Zaman A, Cui Z, Mohan GS, Baldwin HS, Davies PF, Savani RC. Loss of PECAM-1 function impairs alveolarization. J Biol Chem 281: 8724-8731, 2006. (Pubitemid 43847977)
5. deMello DE, Sawyer D, Galvin N, Reid LM. Early fetal development of lung vasculature. Am J Respir Cell Mol Biol 16: 568-581, 1997.
6. Dhanabal M, Ramchandran R, Waterman MJ, Lu H, Knebelmann B, Segal M, Sukhatme VP. Endostatin induces endothelial cell apoptosis. J Biol Chem 274: 11721-11726, 1999. (Pubitemid 129518427)
7. DiMaio TA, Sheibani N. PECAM-1 isoform-specific functions in PECAM-1-deficient brain microvascular endothelial cells. Microvasc Res 75: 188-201, 2008. (Pubitemid 351240941)
8. Dimaio TA, Wang S, Huang Q, Scheef EA, Sorenson CM, Sheibani N. Attenuation of retinal vascular development and neovascularization in PECAM-1-deficient mice. Dev Biol 315: 72-88, 2008.
9. Dimmeler S, Zeiher AM. Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res 87: 434-439, 2000.
10. Folkman J. Angiogenesis and apoptosis. Semin Cancer Biol 13: 159-167, 2003.
11. Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun CO, Buerk DG, Huang PL, Jain RK. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci USA 98: 2604-2609, 2001. (Pubitemid 32209529)
12. Garmy-Susini B, Jin H, Zhu Y, Sung RJ, Hwang R, Varner J. Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation. J Clin Invest 115: 1542-1551, 2005. (Pubitemid 40814662)
13. Gerber HP, Dixit V, Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J Biol Chem 273: 13313-13316, 1998. (Pubitemid 28246905)
14. Iervolino A, Trisciuoglio D, Ribatti D, Candiloro A, Biroccio A, Zupi G, Del Bufalo D.Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity. FASEB J 16: 1453-1455, 2002.
15. Ishida S, Yamashiro K, Usui T, Kaji Y, Ogura Y, Hida T, Honda Y, Oguchi Y, Adamis AP. Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease. Nat Med 9: 781-788, 2003. (Pubitemid 36749230)
16. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, Abman SH. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 279: L600-L607, 2000.
17. Jimenez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL, Bouck N. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 6: 41-48, 2000. (Pubitemid 30048524)
18. Jozkowicz A, Dulak J, Nigisch A, Funovics P, Weigel G, Polterauer P, Huk I, Malinski T. Involvement of nitric oxide in angiogenic activities of vascular endothelial growth factor isoforms. Growth Factors 22: 19-28, 2004. (Pubitemid 38660582)
19. Karsan A, Yee E, Poirier GG, Zhou P, Craig R, Harlan JM. Fibroblast growth factor-2 inhibits endothelial cell apoptosis by Bcl-2-dependent and independent mechanisms. Am J Pathol 151: 1775-1784, 1997. (Pubitemid 27527940)
20. Kim S, Bell K, Mousa SA, Varner JA. Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am J Pathol 156: 1345-1362, 2000. (Pubitemid 30660012)
21. Kondo S, Scheef EA, Sheibani N, Sorenson CM. PECAM-1 isoform-specific regulation of kidney endothelial cell migration and capillary morphogenesis. Am J Physiol Cell Physiol 292: C2070-C2083, 2007. (Pubitemid 47080533)
22. Kondo S, Tang Y, Scheef EA, Sheibani N, Sorenson CM. Attenuation of retinal endothelial cell migration and capillary morphogenesis in the absence of Bcl-2. Am J Physiol Cell Physiol 294: C1521-C1530, 2008.
23. Lawler J. The functions of thrombospondin-1 and -2. Curr Opin Cell Biol 12: 634-640, 2000.
24. Longoni B, Boschi E, Demontis GC, Ratto GM, Mosca F. Apoptosis and adaptive responses to oxidative stress in human endothelial cells exposed to cyclosporin A correlate with BCL-2 expression levels. FASEB J 15: 731-740, 2001.
25. Nor JE, Christensen J, Liu J, Peters M, Mooney DJ, Strieter RM, Polverini PJ. Upregulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res 61: 2183-2188, 2001.
26. Nor JE, Christensen J, Mooney DJ, Polverini PJ. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 154: 375-384, 1999.
27. Rothermel TA, Engelhardt B, Sheibani N. Polyoma virus middle-T-transformed PECAM-1 deficient mouse brain endothelial cells proliferate rapidly in culture and form hemangiomas in mice. J Cell Physiol 202: 230-239, 2005.
28. Ryan US. Isolation and culture of pulmonary endothelial cells. Environ Health Perspect 56: 103-114, 1984.
29. Sakamaki K. Regulation of endothelial cell death and its role in angiogenesis and vascular regression. Curr Neurovasc Res 1: 305-315, 2004.
30. Schachtner SK, Wang Y, Scott Baldwin H. Qualitative and quantitative analysis of embryonic pulmonary vessel formation. Am J Respir Cell Mol Biol 22: 157-165, 2000.
31. Sheibani N, Frazier WA. Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis. Proc Natl Acad Sci USA 92: 6788-6792, 1995.
32. Sheibani N, Scheef EA, DiMaio TA, Wang Y, Kondo S, Sorenson CM. Bcl-2 expression modulates cell adhesion and migration promoting branching of ureteric bud cells. J Cell Physiol 210: 616-625, 2007.
33. Sorenson CM. Interaction of bcl-2 with paxillin through its BH4 domain is important during ureteric bud branching. J Biol Chem 279: 11368-11374, 2004.
34. Sorenson CM, Sheibani N. Sustained activation of MAPK/ERK's signaling pathway in cystic kidneys from Bcl-2-/- mice. Am J Physiol Renal Physiol 283: F1085-F1090, 2002.
35. Stevens T, Phan S, Frid MG, Alvarez D, Herzog E, Stenmark KR. Lung vascular cell heterogeneity: endothelium, smooth muscle, and fibroblasts. Proc Am Thorac Soc 5: 783-791, 2008.
36. Su X, Sorenson CM, Sheibani N. Isolation and characterization of murine retinal endothelial cells. Mol Vis 9: 171-178, 2003.
37. Tang Y, Scheef EA, Wang S, Sorenson CM, Marcus CB, Jefcoate CR, Sheibani N. CYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expression. Blood 113: 744-754, 2009.
38. van Tuyl M, Groenman F, Wang J, Kuliszewski M, Liu J, Tibboel D, Post M. Angiogenic factors stimulate tubular branching morphogenesis of sonic hedgehog-deficient lungs. Dev Biol 303: 514-526, 2007.
39. van Tuyl M, Liu J, Wang J, Kuliszewski M, Tibboel D, Post M. Role of oxygen and vascular development in epithelial branching morphogenesis of the developing mouse lung. Am J Physiol Lung Cell Mol Physiol 288: L167-L178, 2005.
40. Wang S, Sorenson CM, Sheibani N. Attenuation of retinal vascular development and neovascularization during oxygen-induced ischemic retinopathy in Bcl-2-/- mice. Dev Biol 279: 205-219, 2005.
41. Wang S, Wu Z, Sorenson CM, Lawler J, Sheibani N. Thrombospondin-1- deficient mice exhibit increased vascular density during retinal vascular development and are less sensitive to hyperoxia-mediated vessel obliteration. Dev Dyn 228: 630-642, 2003.
42. Xin X, Yang S, Ingle G, Zlot C, Rangell L, Kowalski J, Schwall R, Ferrara N, Gerritsen ME. Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am J Pathol 158: 1111-1120, 2001.
43. Zagzag D, Shiff B, Jallo GI, Greco MA, Blanco C, Cohen H, Hukin J, Allen JC, Friedlander DR. Tenascin-C promotes microvascular cell migration and phosphorylation of focal adhesion kinase. Cancer Res 62: 2660-2668, 2002.
44. Zeitlin BD, Joo E, Dong Z, Warner K, Wang G, Nikolovska-Coleska Z, Wang S, Nor JE. Antiangiogenic effect of TW37, a small-molecule inhibitor of Bcl-2. Cancer Res 66: 8698-8706, 2006.
45. Ziehr J, Sheibani N, Sorenson CM. Alterations in cell adhesive and migratory properties of proximal tubule and collecting duct cells from bcl-2-/- mice. Am J Physiol Renal Physiol 287: F1154-F1163, 2004.